Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study

Details

Request a copyRequest a copy
Serval ID
serval:BIB_34BED0C92D50
Type
Autre: use this type when nothing else fits.
Collection
Publications
Institution
UNIL/CHUV
Title
Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Author(s)
Petit Pierre-Florent (co-first), Daoudlarian Douglas (co-first), Latifyan Sofiya, Bouchaab Hasna, Mederos Nuria, Doms Jacqueline, Abdelhamid Karim, Ferahta Nabila, Mencarelli Lucrezia, Joo Victor, Bartolini Robin, Stravodimou Athina, Shabafrouz Keyvan, Pantaleo Giuseppe, Peters Solange, Obeid Michel
OAI-PMH
oai:serval.unil.ch:BIB_34BED0C92D50
DOI
10.1101/2024.07.12.24310208
Create date
19/07/2024 9:44
Last modification date
20/07/2024 7:06
Usage data